Alestramustine
A chemotherapeutic agent used in cancer treatment
| Alestramustine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Alestramustine is a chemotherapeutic agent that combines the properties of an alkylating agent and an estrogen. It is primarily used in the treatment of prostate cancer.
Mechanism of Action
Alestramustine is a prodrug that is metabolized into two active components: estradiol and normustine. The estradiol component acts as an estrogen, which can help in reducing the levels of testosterone, a hormone that can promote the growth of prostate cancer cells. The normustine component is an alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their ability to divide and grow.
Pharmacokinetics
Upon administration, alestramustine is absorbed and metabolized in the body. The estradiol component is responsible for the hormonal effects, while the normustine component provides the cytotoxic effects. The drug is designed to target cancer cells more effectively by utilizing the affinity of estradiol for estrogen receptors, which are often overexpressed in certain types of cancer cells.
Clinical Use
Alestramustine is used in the treatment of hormone-sensitive prostate cancer. It is particularly useful in cases where other forms of hormone therapy have failed. The combination of hormonal and cytotoxic effects makes it a valuable option in the management of advanced prostate cancer.
Side Effects
The use of alestramustine can lead to several side effects, which are typical of both estrogenic and alkylating agents. Common side effects include:
More serious side effects can include:
Administration
Alestramustine is typically administered orally. The dosage and treatment regimen depend on the specific needs of the patient and the stage of the cancer.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD